Senti Biosciences (SNTI) Change in Cash (2021 - 2025)
Senti Biosciences has reported Change in Cash over the past 5 years, most recently at $4.2 million for Q4 2025.
- For Q4 2025, Change in Cash fell 88.97% year-over-year to $4.2 million; the TTM value through Dec 2025 reached -$31.9 million, down 357.68%, while the annual FY2025 figure was -$31.9 million, 357.68% down from the prior year.
- Change in Cash for Q4 2025 was $4.2 million at Senti Biosciences, up from -$9.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $101.7 million in Q2 2022 and troughed at -$57.2 million in Q4 2022.
- A 5-year average of -$1.9 million and a median of -$6.4 million in 2023 define the central range for Change in Cash.
- On a YoY basis, Change in Cash climbed as much as 9167.98% in 2022 and fell as far as 6537.26% in 2022.
- Year by year, Change in Cash stood at $889323.0 in 2021, then crashed by 6537.26% to -$57.2 million in 2022, then surged by 88.86% to -$6.4 million in 2023, then skyrocketed by 692.08% to $37.8 million in 2024, then tumbled by 88.97% to $4.2 million in 2025.
- Business Quant data shows Change in Cash for SNTI at $4.2 million in Q4 2025, -$9.3 million in Q3 2025, and -$12.2 million in Q2 2025.